5-(9,9-dimethyl-3H-fluoren-3-id-2-yl)-2-methyltetrazole;1-(9,9-dimethyl-3H-fluoren-3-id-2-yl)-3-methyltriazol-1-ium;4-(9,9-dimethyl-3H-fluoren-3-id-2-yl)-1,3-oxazole;4-(9,9-dimethyl-3H-fluoren-3-id-2-yl)-1,3-thiazole;hexakis(iridium);3-(3-phenylbenzene-6-id-1-yl)-1,2,4-oxadiazole;1-phenyl-3-(3-phenylbenzene-6-id-1-yl)triazol-3-ium;platinum;3-(3-pyridin-2-ylbenzene-6-id-1-yl)-1,2,4-thiadiazole;2-[3-(2-thiophen-2-yltetrazol-5-yl)benzene-4-id-1-yl]pyridine
C134H102Ir6N22O2Pt2S3-6 — CID 158617825
Data last refreshed: (MolForge compound catalog, from PubChem)
About 5-(9,9-dimethyl-3H-fluoren-3-id-2-yl)-2-methyltetrazole;1-(9,9-dimethyl-3H-fluoren-3-id-2-yl)-3-methyltriazol-1-ium;4-(9,9-dimethyl-3H-fluoren-3-id-2-yl)-1,3-oxazole;4-(9,9-dimethyl-3H-fluoren-3-id-2-yl)-1,3-thiazole;hexakis(iridium);3-(3-phenylbenzene-6-id-1-yl)-1,2,4-oxadiazole;1-phenyl-3-(3-phenylbenzene-6-id-1-yl)triazol-3-ium;platinum;3-(3-pyridin-2-ylbenzene-6-id-1-yl)-1,2,4-thiadiazole;2-[3-(2-thiophen-2-yltetrazol-5-yl)benzene-4-id-1-yl]pyridine
5-(9,9-dimethyl-3H-fluoren-3-id-2-yl)-2-methyltetrazole;1-(9,9-dimethyl-3H-fluoren-3-id-2-yl)-3-methyltriazol-1-ium;4-(9,9-dimethyl-3H-fluoren-3-id-2-yl)-1,3-oxazole;4-(9,9-dimethyl-3H-fluoren-3-id-2-yl)-1,3-thiazole;hexakis(iridium);3-(3-phenylbenzene-6-id-1-yl)-1,2,4-oxadiazole;1-phenyl-3-(3-phenylbenzene-6-id-1-yl)triazol-3-ium;platinum;3-(3-pyridin-2-ylbenzene-6-id-1-yl)-1,2,4-thiadiazole;2-[3-(2-thiophen-2-yltetrazol-5-yl)benzene-4-id-1-yl]pyridine (PubChem CID 158617825) has the molecular formula C134H102Ir6N22O2Pt2S3-6 and a molecular weight of 3692.10 g/mol. Its IUPAC name is 5-(9,9-dimethyl-3H-fluoren-3-id-2-yl)-2-methyltetrazole;1-(9,9-dimethyl-3H-fluoren-3-id-2-yl)-3-methyltriazol-1-ium;4-(9,9-dimethyl-3H-fluoren-3-id-2-yl)-1,3-oxazole;4-(9,9-dimethyl-3H-fluoren-3-id-2-yl)-1,3-thiazole;hexakis(iridium);3-(3-phenylbenzene-6-id-1-yl)-1,2,4-oxadiazole;1-phenyl-3-(3-phenylbenzene-6-id-1-yl)triazol-3-ium;platinum;3-(3-pyridin-2-ylbenzene-6-id-1-yl)-1,2,4-thiadiazole;2-[3-(2-thiophen-2-yltetrazol-5-yl)benzene-4-id-1-yl]pyridine.
Molecular Properties
| Compound Name | 5-(9,9-dimethyl-3H-fluoren-3-id-2-yl)-2-methyltetrazole;1-(9,9-dimethyl-3H-fluoren-3-id-2-yl)-3-methyltriazol-1-ium;4-(9,9-dimethyl-3H-fluoren-3-id-2-yl)-1,3-oxazole;4-(9,9-dimethyl-3H-fluoren-3-id-2-yl)-1,3-thiazole;hexakis(iridium);3-(3-phenylbenzene-6-id-1-yl)-1,2,4-oxadiazole;1-phenyl-3-(3-phenylbenzene-6-id-1-yl)triazol-3-ium;platinum;3-(3-pyridin-2-ylbenzene-6-id-1-yl)-1,2,4-thiadiazole;2-[3-(2-thiophen-2-yltetrazol-5-yl)benzene-4-id-1-yl]pyridine |
|---|---|
| PubChem CID | 158617825 |
| Molecular Formula | C134H102Ir6N22O2Pt2S3-6 |
| Molecular Weight | 3692.10 g/mol |
| Exact Mass | 3694.48 |
| IUPAC Name | 5-(9,9-dimethyl-3H-fluoren-3-id-2-yl)-2-methyltetrazole;1-(9,9-dimethyl-3H-fluoren-3-id-2-yl)-3-methyltriazol-1-ium;4-(9,9-dimethyl-3H-fluoren-3-id-2-yl)-1,3-oxazole;4-(9,9-dimethyl-3H-fluoren-3-id-2-yl)-1,3-thiazole;hexakis(iridium);3-(3-phenylbenzene-6-id-1-yl)-1,2,4-oxadiazole;1-phenyl-3-(3-phenylbenzene-6-id-1-yl)triazol-3-ium;platinum;3-(3-pyridin-2-ylbenzene-6-id-1-yl)-1,2,4-thiadiazole;2-[3-(2-thiophen-2-yltetrazol-5-yl)benzene-4-id-1-yl]pyridine |
| SMILES | CC1(C)c2ccccc2-c2c[c-]c(-c3cocn3)cc21.CC1(C)c2ccccc2-c2c[c-]c(-c3cscn3)cc21.Cn1cc[n+](-c2[c-]cc3c(c2)C(C)(C)c2ccccc2-3)n1.Cn1nnc(-c2[c-]cc3c(c2)C(C)(C)c2ccccc2-3)n1.[Ir].[Ir].[Ir].[Ir].[Ir].[Ir].[Pt].[Pt].[c-]1ccc(-c2ccccc2)cc1-[n+]1ccn(-c2ccccc2)n1.[c-]1ccc(-c2ccccc2)cc1-c1ncon1.[c-]1ccc(-c2ccccn2)cc1-c1ncsn1.[c-]1ccc(-c2ccccn2)cc1-c1nnn(-c2cccs2)n1 |
| InChI | InChI=1S/C20H15N3.C18H17N3.C18H14NO.C18H14NS.C17H15N4.C16H10N5S.C14H9N2O.C13H8N3S.6Ir.2Pt/c1-3-8-17(9-4-1)18-10-7-13-20(16-18)23-15-14-22(21-23)19-11-5-2-6-12-19;1-18(2)16-7-5-4-6-14(16)15-9-8-13(12-17(15)18)21-11-10-20(3)19-21;2*1-18(2)15-6-4-3-5-13(15)14-8-7-12(9-16(14)18)17-10-20-11-19-17;1-17(2)14-7-5-4-6-12(14)13-9-8-11(10-15(13)17)16-18-20-21(3)19-16;1-2-9-17-14(7-1)12-5-3-6-13(11-12)16-18-20-21(19-16)15-8-4-10-22-15;1-2-5-11(6-3-1)12-7-4-8-13(9-12)14-15-10-17-16-14;1-2-7-14-12(6-1)10-4-3-5-11(8-10)13-15-9-17-16-13;;;;;;;;/h1-12,14-16H;4-7,9-12H,1-3H3;2*3-6,8-11H,1-2H3;4-7,9-10H,1-3H3;1-5,7-11H;1-7,9-10H;1-4,6-9H;;;;;;;;/q;;6*-1;;;;;;;; |
| InChIKey | URIRSHNHXDEDPJ-UHFFFAOYSA-N |
| XLogP | 28.27 |
| TPSA | 260.00 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 25 |
| Rotatable Bonds | 14 |
| Heavy Atoms | 169 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 3692.10 |
| LogP ≤ 5 | 28.27 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 25 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Carbo_cation/anion', 'substructure': 'N/A'}, {'alert_name': 'quaternary_nitrogen_1', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158617825 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.